잠시만 기다려 주세요. 로딩중입니다.

Coronavirus Disease 2019 환자의 당뇨병 관리: 예후 및 임상적 고려사항들

Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues

Journal of Korean Diabetes 2020년 21권 3호 p.120 ~ 125
김혜순,
소속 상세정보
김혜순 ( Kim Hye-Soon ) - Keimyung University School of Medicine Department of Internal Medicine Division of Endocrinology and Metabolism

Abstract


The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a global pandemic by the World Health Organization on March 11, 2020. COVID-19 pandemic emphasizes the importance of understanding the pathophysiology which can potentially influence the treatment choices of people with chronic disease such as type 2 diabetes. The reasons for worse prognosis with COVID-19 in people with diabetes include age, sex, ethnicity, comorbidities such as hypertension, cardiovascular disease, obesity and a proinflammatory status. Medications for glucose-lowering and antihypertensive agents should be carefully assessed which can modulate the risk or may have potential interactions with SARS-CoV-2. It is also important to note that SARS-CoV-2 may exacerbate glucose metabolism through direct beta-cell damage, leading to acute hyperglycemic complications and potential new onset diabetes.

키워드

Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Type 2 diabetes

원문 및 링크아웃 정보

등재저널 정보